期刊文献+

酒石酸美托洛尔脉冲微丸的制备

Preparation of metoprolol tartrate pulsatile pellets and the influencing factors of dissolution in vitro
原文传递
导出
摘要 目的研究酒石酸美托洛尔脉冲微丸的制备和体外释放度。方法采用碱诱导原理制备酒石酸美托洛尔脉冲微丸,考察制备工艺中不同因素对脉冲微丸体外释放度的影响。结果碱性层增加质量不同、迟滞层增加质量不同、迟滞层组成不同、增塑剂用量不同和不同粒径的丸芯均会影响脉冲微丸的体外释放。结论碱诱导原理制备脉冲微丸的方法操作简便,条件可控,制得微丸的脉冲效果理想。 Objective To study the preparation of metoprolol tartrate pulsatile pellets and its in vitro dissolution. Methods The metoprolol tartrate pulsatile pellets were prepared by evocation of alkaline layer. The effects of different factors on dissolution in vitro during the preparation of pulsatile pellets were studied. Results The dissolution of metoprolol tartrate pulsatile pellets in vitro was influenced in varying degrees by increased weight of alkaline layer, increased weight and composition of out-layer coating level, dosage of plasticizer, and particle size of pellets. Conclusion The preparation of metoprolol tartrate pulsatile pellets by evocation of alkaline layer is practical and controllable, and the pulse effect of metoprolol tartrate pulsatile pellets is good.
出处 《现代药物与临床》 CAS 2010年第5期364-368,共5页 Drugs & Clinic
基金 国家科技支撑计划项目子项目(2007BAI41B05)
关键词 酒石酸美托洛尔 脉冲微丸 碱诱导 体外释放 metoprolol tartrate pulsatile pellet alkaline layer evocation in vitro dissolution
  • 相关文献

参考文献7

  • 1顾东风.心血管病预防的现状和展望[J].中华预防医学杂志,2003,37(2):75-76. 被引量:78
  • 2Zhang Y, Zhang Z R, Wu F, et al. A novel pulsed-release system based on swelling and osmotic pumping mechanism [J], J Control'Rel, 2003, 89 (1): 47-55. 被引量:1
  • 3Bussemer T, Otto I, Bodmeier R. Pulsatile drug-delivery systems [J]. Crit Rev Ther Drug Carrier Syst, 2001, 18 (5): 433-458. 被引量:1
  • 4Ishino R, Yoshino H, Hirakawa Y, et al. Design and preparation of pulsatile release tablet as a new oral drug delivery system [J]. Chem Pharm Bull, 1992, 40 (11): 3036-3044. 被引量:1
  • 5郝钦,岗艳云,朱家壁.硝酸异山梨酯脉冲控释微丸的研制[J].中国医药工业杂志,1999,30(3):109-112. 被引量:20
  • 6Khan M Z I, Prebeg Z, Kurjakovie N, et al. ApH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers Manipulation of drug release using Eudragit (R) L100-55 and Eudragit (R) S100 combinations [J]. J Control Rel, 1999, 58 (3): 215-222. 被引量:1
  • 7Peh K K, Wong C F. Application of similarity factor in development of controlled-release diltiazem tablet [J]. Drug Dev Ind Pharm, 2000, 26 (7): 723-730. 被引量:1

二级参考文献1

共引文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部